Takuya Ebihara Selected Research

imarikiren hydrochloride

5/2019

The effect of elevated α1-acid glycoprotein on the pharmacokinetics of TAK-272 (SCO-272), an orally active renin inhibitor, in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takuya Ebihara Research Topics

Disease

3	Inflammation (Inflammations) 05/2019 - 01/2017
2	Type 2 Diabetes Mellitus (MODY) 01/2019 - 01/2017
1	Body Weight (Weight, Body) 01/2019
1	Chemical and Drug Induced Liver Injury 01/2017
1	Neoplasms (Cancer) 06/2003
1	Chronic Idiopathic Jaundice (Dubin Johnson Syndrome) 11/2002

Drug/Important Bio-Agent (IBA)

2	TAK-875IBA 01/2019 - 01/2017
1	imarikiren hydrochlorideIBA 05/2019
1	Renin InhibitorsIBA 05/2019
1	TurpentineIBA 05/2019
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2019
1	Bile Acids and Salts (Bile Acids)IBA 01/2017
1	Nonesterified Fatty Acids (NEFA)IBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 06/2003
1	Leukotriene C4IBA 06/2003
1	AnionsIBA 06/2003
1	multidrug resistance-associated protein 1IBA 06/2003
1	cysteinyl-leukotrieneIBA 06/2003
1	Adenosine Triphosphate (ATP)IBA 11/2002